Cardiff Oncology Inc. buy michaelkr
Start price
02.10.22
/
50%
€1.58
Target price
02.10.23
-
Performance (%)
-21.43%
End price
17.11.22
€1.24
Summary
This prediction ended on 17.11.22 with a price of €1.24. The prediction for Cardiff Oncology Inc. disappointed with a performance of -21.43%. michaelkr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | 9.677% | 9.677% | -34.510% | 60.377% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to michaelkr what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by michaelkr for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.
In the thread Trading Trovagene
Stopped prediction by michaelkr for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.74
22.06.25
22.06.25
-
22.06.26
22.06.26
18.80%
05.07.25
05.07.25
Could be worthwhile Investment >10% per year
